Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00875758 · ClinicalTrials.gov registry record · NA
Optimizing Treatment of Post-hemorrhagic Ventricular Dilation in Preterm Infants
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT00875758 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 7 participants.
The verdict
NCT00875758, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
Intraventricular hemorrhage remains the most frequent, severe neurological complication of prematurity, occurring in 25-30% of preterm infants. Post-hemorrhagic ventricular dilation (PHVD) occurs in 25-50% of those infants, with over half requiring ventriculoperitoneal shunts. When suboptimally untreated, PVHD results in a 3-4 fold increase in neurodevelopmental delay. Despite the lifelong impact of PHVD on quality of life, little research has been done over the past 20 years to improve patient outcomes. The CENTRAL HYPOTHESIS of this project is that early treatment of PHVD will reduce shunt-dependence and improve neurodevelopmental outcome in preterm infants.
Interventions
- PROCEDURE Removal of CSF through ventricular access device
- PROCEDURE Removal of CSF through a ventricular access device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2009-05 |
| Est. Completion | 2013-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00875758
The ClinicalTrials.gov registry entry for NCT00875758 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Removal of CSF through ventricular access device is the first listed.
NCT00875758 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00875758 about?
NCT00875758 is a clinical study titled "Optimizing Treatment of Post-hemorrhagic Ventricular Dilation in Preterm Infants". Intraventricular hemorrhage remains the most frequent, severe neurological complication of prematurity, occurring in 25-30% of preterm infants. Post-hemorrhagic ventricular dilation (PHVD) occurs in 25-50% of those infants, with over half requiring ventriculoperitoneal shunts. When suboptimally untr...
What is the current status of trial NCT00875758?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2009-05. Estimated completion is 2013-11.
What interventions are being tested in trial NCT00875758?
The interventions under investigation include: Removal of CSF through ventricular access device (PROCEDURE), Removal of CSF through a ventricular access device (PROCEDURE).
Who is sponsoring clinical trial NCT00875758?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.